Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled study.
作者:
主题词
成年人(Adult);老年人(Aged);血管生成抑制剂(Angiogenesis Inhibitors);脉络膜新生血管化(Choroidal Neovascularization);女(雌)性(Female);荧光素血管造影术(Fluorescein Angiography);随访研究(Follow-Up Studies);人类(Humans);玻璃体内注射(Intravitreal Injections);男(雄)性(Male);中年人(Middle Aged);近视, 退行性(Myopia, Degenerative);前瞻性研究(Prospective Studies);单盲法(Single-Blind Method);体层摄影术, 光学相干(Tomography, Optical Coherence);治疗结果(Treatment Outcome);血管内皮生长因子A(Vascular Endothelial Growth Factor A);视敏度(Visual Acuity);青年人(Young Adult)
DOI
10.1111/ceo.13424
PMID
30345611
发布时间
2020-04-10
- 浏览14
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文